ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Open Access Publisher Responds to White House with NO APC for Negative Research

By: WebWire

Partners in Digital Health (PDH) has announced a new, no APC fee, open access policy aimed specifically at negative, unconventional, null, neutral, and failed research, on the heels of the White House Office of Science and Technology Policy (OSTP) Federally Funded Research Guidance announcement.

A journal spokesperson stated: “Progress in science is not only made based on positive data, but also on negative results. Guidance to the scientific community should include and emphasize the importance of negative data across both public and open access scientific publications.” Scientists have become accustomed to celebrating only success and have forgotten that most technological advances stem from failure. When negative results aren't published in high-impact journals, other scientists can't learn from them and end up repeating failed experiments, leading to a waste of public funds and a delay in genuine progress.

Researchers are particularly challenged to disclose negative results that are not consistent with previously published positive data. In addition, positive findings are more likely to generate citations and funding for additional research, but negative data saves institutions funding wasteful projects and puts ecosystems on the right track for faster solutions and outcomes that benefit the entire ecosystem. This is critically important in new research fields and markets that are evolving - fostering real world applications and scaled implementations.

Partners in Digital Health is pleased to facilitate these critical efforts to accelerate research success, augment true innovation, and create a trusted repository where research, public, and private communities can find unconventional answers to streamline meaningful solutions. The publisher will waive the APC for negative and null research, for accepted peer reviewed manuscript submissions.

Negative results are not typically cited, and discouraged in academia, but are essential to advancing knowledge in the field, and may contribute to changing reward systems in academia in the future.

Topic areas will include but are not limited to the following:


  • What and why the research did not work, eg., rigor in study design, lack of funding, issue with patient recruitment, support from superiors or colleagues, bias, etc
  • Analysis of impact
  • Consequences of negative research
  • Lessons on mitigating negative results and why
  • Benefits of sharing research
  • Good research practices, best practices
  • Key personal learnings
  • Addressing issues of reproducibility
  • Ethical violations


Papers on related and complementary topics will be considered.

Submission Requirements


  • Papers should be original submissions not previously published or under active consideration by other journal
  • Papers will be 3,000 maximum word count
  • Submissions must include a section for an analysis and recommendations for future researchers, and journal readers


All papers will be peer reviewed and follow the journal's peer review process and workflow. There is no deadline for these manuscripts. Submissions may be from any country.

For questions regarding the suitability of a particular paper, send inquiries to info@partnersindigitalhealth.com

For further details visit:
Blockchain in Healthcare Today – click here for Call for Manuscripts

Telehealth and Medicine Today – click here for Call for Manuscripts

— WebWireID294090 —


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.